Jeena Sikho Lifecare Q1 FY27 Investor Presentation: Revenue Up 29%, PAT Rises 28% as Ayurveda Healthcare Scales

What Happened ?

Jeena Sikho Lifecare reported a strong opening quarter for FY27, supported by growth in both its Ayurveda Healthcare Services and Ayurveda Healthcare Products businesses. Revenue from Operations increased 29% YoY, while EBITDA grew 17% and the EBITDA margin stood at 41%. 

The company also recorded strong underlying volume growth. IPD patient volumes increased 33% YoY to 11,500, while day-care volumes rose 31% YoY to 19,419 patients per day. The company said its expanding network and increasing awareness of Ayurveda are supporting demand for its healthcare services. 

key details

Strong Q1 FY27 Financial Performance:

• Revenue from Operations increased 29% YoY to ₹224.4 crore.
• EBITDA increased 17% YoY to ₹92.1 crore.
• EBITDA margin stood at 41%.
• PAT increased 28% YoY to ₹65.7 crore.
• PAT margin stood at approximately 29%.
• Profitability improved sequentially, with EBITDA increasing 18% QoQ and PAT increasing 45% QoQ.

Note:

• The quarterly performance reflects growth across both operating verticals, while the company continued to scale its healthcare network and product portfolio. 

Ayurveda Healthcare Products Drive Growth:

• Products revenue reached ₹118 crore, contributing 53% of Q1 FY27 revenue.
• Revenue grew 47% YoY during the quarter.
• Product gross margin stood at 86%.
• Portfolio expanded to 330+ Ayurveda SKUs.
• The INJK Water Device, launched in December 2024, became the largest contributor to the product portfolio during Q1 FY27.
• New product categories include plant-based protein, joint-care products and other specialized Ayurveda offerings.

Note:

• The products vertical combines healthcare-centre sales, tele-calling, e-commerce and B2B sales through franchise centres, creating multiple channels for customer acquisition and repeat purchases. 

Healthcare Services Maintain Volume Momentum:

• Services revenue stood at ₹106 crore, representing 47% of Q1 FY27 revenue.
• Services gross margin stood at 91%.
• IPD patient volumes increased 33% YoY to 11,500.
• Day-care volumes increased 31% YoY to 19,419 per day.
• OPD patient volumes increased 22% YoY to 1.51 lakh.
• VOPD consultations increased 65% YoY to 69,119.
• OPD, COD and consultation customers reached 5.0 lakh, up 143% YoY.

Note:

• The company’s service network is designed around hospitals, clinics and day-care centres, with healthcare services and product sales integrated through a cross-selling model. 

Network Expansion Supports Capacity Growth:

• 62 hospitals operational.
• 57 clinics and day-care centres operational.
• Approximately 2,400 beds operational.
• 450 beds in the pipeline.
• Presence across 23 states and 100+ cities and towns.
• Five facilities are currently in the pipeline.
• The company has 51 NABH-accredited hospitals and clinics, with two additional AYUSH hospital accreditations in the pipeline.

Note:

• The expanding network is intended to increase treatment capacity and deepen Jeena Sikho’s presence across regions. 

Capital-Light Business Model:

• Management describes the healthcare model as capital-light.
• Estimated capex is approximately ₹3–4 lakh per bed, compared with ₹30–50 lakh+ for allopathic facilities, according to the presentation.
• The company uses leased facilities and a franchise model for clinics.
• Product manufacturing is outsourced to AYUSH-compliant third-party manufacturers.
• Management highlights a low variable-cost structure and scalable facility model.

Note:

• The company estimates approximately 35% break-even occupancy under its standard operating-cost structure and highlights the potential for rapid payback as facilities scale. These are company estimates rather than reported historical outcomes. 

New Ultra-Luxury Wellness Initiative:

• Jeena Sikho has signed its first wellness resort in Manali, Himachal Pradesh.
• Planned development includes 108 rooms.
• The property includes access to 20+ acres of private forest.
• 22 villas are planned.
• A helipad is planned as part of the upcoming phase.
• The project marks the company’s entry into the ultra-luxury premium wellness market.

Note:

• The Manali initiative represents a new business direction beyond the company’s existing Ayurveda healthcare services and products operations. 

Sales Funnel & Customer Acquisition:

• The company reported 16 million followers across its social media channels.
• Q1 FY27 included four 72-hour healthcare camps.
• These camps attracted 309 cumulative visitors during the quarter.
• The company uses social media, client-support operations, healthcare camps, traditional media and e-commerce as customer acquisition channels.
• Management highlights an approximate 30% conversion of camp attendees into IPD treatments.

Note:

• The company considers its digital reach and healthcare-camp strategy an important component of its patient acquisition and brand-building model. 

Risk Analysis

Summary:

• Jeena Sikho Lifecare is expanding rapidly across healthcare services, products and wellness, but its future performance remains dependent on successful execution of network expansion, patient acquisition, product acceptance and the scalability of its business model.

Key Risks:

• Execution risk associated with rapid healthcare-centre expansion.
• Competition within the healthcare and wellness market.
• Dependence on continued patient and customer acquisition.
• Product portfolio and channel expansion risks.
• Execution risk associated with the new premium wellness initiative.
• Changes in consumer preferences and market conditions.
• Regulatory or operational changes affecting the healthcare business.

Worst Case:

• If network expansion does not translate into sufficient patient volumes, new facilities take longer to reach targeted utilization, or new initiatives fail to scale as planned, the company’s growth and operating leverage could weaken.

Risk Level: Medium

Conclusion

• Jeena Sikho commenced FY27 with healthy growth across both core business verticals.
• Management highlighted higher patient footfalls and a wider service network as key service-business growth drivers.
• The Ayurveda Healthcare Products business remains a major growth engine.
• Approximately 2,400 operational beds provide a platform for further expansion.
• Management expects continued network expansion to increase treatment capacity and support volume-led growth.
• The company is also expanding into premium wellness through its Manali project.